Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 4 | 2008 | 81 | 0.870 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2008 | 186 | 0.820 |
Why?
|
| Biomedical Research | 2 | 2023 | 502 | 0.670 |
Why?
|
| Zirconium | 3 | 2016 | 11 | 0.660 |
Why?
|
| Education, Graduate | 2 | 2015 | 31 | 0.490 |
Why?
|
| Ganglia, Spinal | 2 | 2017 | 42 | 0.480 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 35 | 0.470 |
Why?
|
| Elapid Venoms | 1 | 2015 | 16 | 0.460 |
Why?
|
| Doxorubicin | 1 | 2016 | 97 | 0.450 |
Why?
|
| Drug Carriers | 2 | 2016 | 174 | 0.450 |
Why?
|
| Career Choice | 2 | 2015 | 52 | 0.400 |
Why?
|
| Documentation | 1 | 2012 | 18 | 0.380 |
Why?
|
| Physiology | 1 | 2012 | 17 | 0.380 |
Why?
|
| Career Mobility | 1 | 2012 | 29 | 0.380 |
Why?
|
| Mentors | 3 | 2023 | 145 | 0.330 |
Why?
|
| Nanoparticles | 1 | 2016 | 460 | 0.320 |
Why?
|
| Neurons | 1 | 2015 | 1263 | 0.280 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.270 |
Why?
|
| Environment | 1 | 2008 | 149 | 0.250 |
Why?
|
| Papillomaviridae | 2 | 2005 | 142 | 0.250 |
Why?
|
| DNA, Viral | 2 | 2005 | 311 | 0.240 |
Why?
|
| Neoplasms | 1 | 2016 | 1377 | 0.220 |
Why?
|
| Trans-Activators | 1 | 2005 | 192 | 0.210 |
Why?
|
| Intercalating Agents | 2 | 2013 | 13 | 0.190 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 561 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2005 | 376 | 0.160 |
Why?
|
| Humans | 13 | 2023 | 43102 | 0.150 |
Why?
|
| Peer Review, Research | 1 | 2018 | 15 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2018 | 89 | 0.140 |
Why?
|
| Echinococcosis | 1 | 2017 | 1 | 0.130 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2017 | 9 | 0.130 |
Why?
|
| Writing | 2 | 2018 | 42 | 0.130 |
Why?
|
| Research Personnel | 1 | 2018 | 206 | 0.130 |
Why?
|
| Helminth Proteins | 1 | 2017 | 26 | 0.120 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 79 | 0.120 |
Why?
|
| Rats, Long-Evans | 1 | 2015 | 108 | 0.110 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2005 | 17 | 0.110 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2005 | 25 | 0.110 |
Why?
|
| Female | 7 | 2016 | 24698 | 0.110 |
Why?
|
| Cisplatin | 1 | 2013 | 98 | 0.100 |
Why?
|
| Receptors, Histamine | 1 | 2013 | 3 | 0.100 |
Why?
|
| Histamine Antagonists | 1 | 2013 | 6 | 0.100 |
Why?
|
| Job Application | 1 | 2012 | 3 | 0.100 |
Why?
|
| Organizational Objectives | 1 | 2012 | 33 | 0.100 |
Why?
|
| Professional Competence | 1 | 2012 | 42 | 0.090 |
Why?
|
| Staff Development | 1 | 2012 | 30 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2005 | 273 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 93 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1621 | 0.090 |
Why?
|
| Minority Health | 1 | 2011 | 95 | 0.090 |
Why?
|
| Nanocapsules | 1 | 2010 | 19 | 0.080 |
Why?
|
| Communication | 1 | 2012 | 210 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 230 | 0.080 |
Why?
|
| Students | 1 | 2015 | 626 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2010 | 176 | 0.070 |
Why?
|
| Education, Medical | 1 | 2010 | 118 | 0.070 |
Why?
|
| Insulin | 1 | 2010 | 258 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 184 | 0.070 |
Why?
|
| Male | 4 | 2015 | 23409 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 2853 | 0.070 |
Why?
|
| Risk Factors | 2 | 2008 | 3994 | 0.070 |
Why?
|
| Aged | 3 | 2005 | 8214 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 590 | 0.060 |
Why?
|
| Life Style | 1 | 2008 | 334 | 0.060 |
Why?
|
| Animals | 4 | 2017 | 16992 | 0.060 |
Why?
|
| Smad4 Protein | 1 | 2005 | 8 | 0.060 |
Why?
|
| Prognosis | 1 | 2008 | 861 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1019 | 0.060 |
Why?
|
| Middle Aged | 3 | 2005 | 12222 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 374 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 455 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 13 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 216 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 60 | 0.050 |
Why?
|
| Demography | 1 | 2003 | 195 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 934 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 154 | 0.050 |
Why?
|
| Capacity Building | 1 | 2023 | 99 | 0.050 |
Why?
|
| Rats | 3 | 2017 | 3735 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 1067 | 0.040 |
Why?
|
| Incidence | 1 | 2003 | 1078 | 0.040 |
Why?
|
| Alcoholism | 1 | 2003 | 305 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2003 | 1413 | 0.040 |
Why?
|
| Cell Survival | 2 | 2013 | 945 | 0.040 |
Why?
|
| Adult | 2 | 2005 | 13872 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 240 | 0.030 |
Why?
|
| Echinococcus granulosus | 1 | 2017 | 1 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2017 | 13 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2017 | 228 | 0.030 |
Why?
|
| Smoking | 1 | 2003 | 1024 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 283 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2005 | 2157 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 236 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 876 | 0.020 |
Why?
|
| Betahistine | 1 | 2013 | 1 | 0.020 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2013 | 1 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 2013 | 5 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2013 | 44 | 0.020 |
Why?
|
| Phylogeny | 1 | 2017 | 769 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 388 | 0.020 |
Why?
|
| Universities | 1 | 2015 | 559 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 64 | 0.020 |
Why?
|
| Pancreas | 1 | 2010 | 45 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1723 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 83 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 159 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 508 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 498 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3156 | 0.020 |
Why?
|